Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Dysphagia
Published in: Dysphagia 1/2007

01-01-2007 | Case Report

Neuroleptic-Induced Dysphagia: Case Report and Literature Review

Authors: Rainer Dziewas, MD, Tobias Warnecke, MD, Martina Schnabel, MD, Martin Ritter, MD, Darius G. Nabavi, MD, Matthias Schilling, MD, E. Bernd Ringelstein, MD, Thomas Reker, MD

Published in: Dysphagia | Issue 1/2007

Login to get access

Abstract

Neuroleptic medication may cause extrapyramidal symptoms (EPS) that can affect swallowing as well. This report describes a case of drug-induced dysphagia in a 53-year-old man receiving haloperidol for treatment of schizophrenia. The diagnosis was established by fiberoptic endoscopic evaluation of swallowing. After changing medication to fluphenazin, dysphagic symptoms resolved. The literature on EPS-related dysphagia, its demographic features, typical symptoms, diagnostic modalities, clinical course, and treatment options is reviewed.
Literature
1.
Fioritti A, Giaccotto L, Melega V: Choking incidents among psychiatric patients: retrospective analysis of thirty-one cases from the west bologna psychiatric ward. Can J Psychiatry 42:515–520, 1997PubMed
2.
Hussar AE, Bragg DG: The effect of chlorpromazine on the swallowing function in chronic schizophrenic patients. Am J Psychiatry 126:152–155, 1969
3.
4.
Bazemore PH, Tonkonogy J, Ananth R: Dysphagia in psychiatric patients: clinical and videofluoroscopic study. Dysphagia 6:2–5, 1991PubMedCrossRef
5.
Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS: Swallowing abnormalities and their responses to treatment in Parkinson’s disease. Neurology 39:1309–1314, 1989PubMed
6.
Gregory RP, Smith PT, Rudge P: Tardive dyskinesia presenting as severe dysphagia. J Neurol Neurosurg Psychiatry 55:1203–1204, 1992PubMed
7.
Langmore SE (ed.): Endoscopic evaluation and treatment of swallowing disorders. New York: Thieme, 2001
8.
Casey DE, Keepers GA: Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia. In: Casey DE, Vibeke Christensen A (eds.): Psychopharmacology: current trends. Berlin: Springer, 1988, pp 74–93
9.
Muscettola G, Barbato G, Pampallona S, Casiello M, Bollini P: Extrapyramidal syndromes in neuroloptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia. J Clin Psychopharmacol 19:203–208, 1999PubMedCrossRef
10.
Binder RL, Kazamatsuri H, Nishimura T, McNiel DE: Tardive dyskinesia and neuroleptic induced parkinsonism in Japan. Am J Psychiatry 144:1494–1496, 1987PubMed
11.
Richardson MA, Craig TJ: The coexistence of parkinsonism-like symptoms and tardive dyskinesia. Am J Psychiatry 139:341–343, 1982PubMed
12.
McCreadie RG, Robertson LJ, Wiles DH: The Nithsdale schizophrenia surveys. IX: akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic level. Br J Psychiatry 161:793–799, 1992
13.
Miller CH, Mohr F, Umbricht D, Woerner M, Fleischhacker WW, Liebermann JA: The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. J Clin Psychiatry 59:69–75, 1998PubMed
14.
Edwards LL, Pfeiffer RF, Quigyley EMM, Hofman R, Balluf M: Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156, 1991PubMedCrossRef
15.
16.
Stewart JT: Reversible dysphagia associated with neuroleptic treatment. J Am Geriatr Soc 49:1260–1261, 2001PubMedCrossRef
17.
18.
19.
Hughes TAT, Shone G, Lindsay G, Wiles CM: Severe dysphagia associated with major tranquilizer treatment. Postgrad Med J 70:581–583, 1994PubMedCrossRef
20.
Bashford G, Bradd P: Drug-induced parkinsonism associated with dysphagia and aspiration: a brief report. J Geriatr Psychiatry Neurol 9:133–135, 1996PubMed
21.
22.
McCarthy RH, Terkelsen KG: Esophageal dysfunction in two patients after clozapine treatment. J Clin Psychopharmacol 14:281–283, 1994PubMed
23.
Sliwa JA, Lis S: Drug-induced dysphagia. Arch Phys Med Rehabil 74:445–447, 1993PubMed
24.
Leopold NA, Kagel MC: Pharyngo-esophageal dysphagia in Parkinson’s disease. Dysphagia 12:11–18, 1997PubMedCrossRef
25.
Metadata
Title
Neuroleptic-Induced Dysphagia: Case Report and Literature Review
Authors
Rainer Dziewas, MD
Tobias Warnecke, MD
Martina Schnabel, MD
Martin Ritter, MD
Darius G. Nabavi, MD
Matthias Schilling, MD
E. Bernd Ringelstein, MD
Thomas Reker, MD
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Dysphagia / Issue 1/2007
Print ISSN: 0179-051X
Electronic ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-006-9032-9

Other articles of this Issue 1/2007

Dysphagia 1/2007 Go to the issue

OriginalPaper

Analysis of Respiratory Complications After Minimally Invasive Esophagectomy: Preliminary Observation of Persistent Aspiration Risk

OriginalPaper

Radiation Dose in Videofluoroscopic Swallow Studies

OriginalPaper

Utility of Ambulatory pH Monitoring and Videofluoroscopy for the Evaluation of Patients with Globus Pharyngeus

ReviewPaper

Comments on Selected Recent Dysphagia Literature

OriginalPaper

Eosinophilic Esophagitis in Infants and Toddlers

OriginalPaper

The First Year of Human Life: Coordinating Respiration and Nutritive Swallowing